New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster

Detalles Bibliográficos
Autores principales: Arismendez, Alan A., Chopra, Jasmine, Campbell, Taylor, Balsiger, Robert, Vickers, Aroucha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892326/
https://www.ncbi.nlm.nih.gov/pubmed/36803930
http://dx.doi.org/10.1016/j.jcjo.2023.01.013
_version_ 1784881307716681728
author Arismendez, Alan A.
Chopra, Jasmine
Campbell, Taylor
Balsiger, Robert
Vickers, Aroucha
author_facet Arismendez, Alan A.
Chopra, Jasmine
Campbell, Taylor
Balsiger, Robert
Vickers, Aroucha
author_sort Arismendez, Alan A.
collection PubMed
description
format Online
Article
Text
id pubmed-9892326
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98923262023-02-02 New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster Arismendez, Alan A. Chopra, Jasmine Campbell, Taylor Balsiger, Robert Vickers, Aroucha Can J Ophthalmol Correspondence Elsevier 2023-02-02 /pmc/articles/PMC9892326/ /pubmed/36803930 http://dx.doi.org/10.1016/j.jcjo.2023.01.013 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Arismendez, Alan A.
Chopra, Jasmine
Campbell, Taylor
Balsiger, Robert
Vickers, Aroucha
New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
title New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
title_full New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
title_fullStr New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
title_full_unstemmed New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
title_short New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
title_sort new-onset mogad after first-dose sars-cov-2 mrna vaccination with relapse following sars-cov-2 mrna booster
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892326/
https://www.ncbi.nlm.nih.gov/pubmed/36803930
http://dx.doi.org/10.1016/j.jcjo.2023.01.013
work_keys_str_mv AT arismendezalana newonsetmogadafterfirstdosesarscov2mrnavaccinationwithrelapsefollowingsarscov2mrnabooster
AT choprajasmine newonsetmogadafterfirstdosesarscov2mrnavaccinationwithrelapsefollowingsarscov2mrnabooster
AT campbelltaylor newonsetmogadafterfirstdosesarscov2mrnavaccinationwithrelapsefollowingsarscov2mrnabooster
AT balsigerrobert newonsetmogadafterfirstdosesarscov2mrnavaccinationwithrelapsefollowingsarscov2mrnabooster
AT vickersaroucha newonsetmogadafterfirstdosesarscov2mrnavaccinationwithrelapsefollowingsarscov2mrnabooster

Ejemplares similares